title: [Drug-induced valvular heart disease].
authors.affiliation: Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Medizinische Klinik mit Schwerpunkt Kardiologie, Augustenburger Platz 1, 13353 Berlin, Germany. daniela.blaschke@charite.de
authors.forename: D
authors.initials: D
authors.lastname: Blaschke
authors.forename: S
authors.initials: S
authors.lastname: Rolf
authors.forename: A S
authors.initials: AS
authors.lastname: Parwani
authors.forename: M
authors.initials: M
authors.lastname: Huemer
authors.forename: R
authors.initials: R
authors.lastname: Dietz
authors.forename: E
authors.initials: E
authors.lastname: Garbe
authors.forename: W
authors.initials: W
authors.lastname: Haverkamp
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000009:adverse effects; D002276:Carcinoid Tumor / Q000150:complications; D018491:Dopamine Agonists / Q000009:adverse effects; D004876:Ergot Alkaloids / Q000009:adverse effects; D006349:Heart Valve Diseases / Q000139:chemically induced*; D006801:Humans; D012701:Serotonin / Q000502:physiology; D018490:Serotonin Agents / Q000009:adverse effects
chemical_list: D000316:Adrenergic alpha-Agonists; D018491:Dopamine Agonists; D004876:Ergot Alkaloids; D018490:Serotonin Agents; D012701:Serotonin